Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-04-25

Clinical Trial Update: TXA in the Reduction of Post-Op Hematoma and Seroma in Patients Undergoing Panniculectomy or Abdominoplasty [Phase 4]

View source ↗

Summary

Clinical trial update for TXA in reducing postoperative hematoma and seroma in panniculectomy or abdominoplasty (Phase 4) has been terminated with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TXA (tranexamic acid)

Snippet

Sponsor: The Reading Hospital and Medical Center | Conditions: Panniculectomy, Abdominoplasty | Phase 4 | Status: TERMINATED | Results posted: 2023-04-25